These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28482611)

  • 1. Cetuximab conjugated and doxorubicin loaded silica nanoparticles for tumor-targeting and tumor microenvironment responsive binary drug delivery of liver cancer therapy.
    Wang JK; Zhou YY; Guo SJ; Wang YY; Nie CJ; Wang HL; Wang JL; Zhao Y; Li XY; Chen XJ
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():944-950. PubMed ID: 28482611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cetuximab-modified silica nanoparticle loaded with ICG for tumor-targeted combinational therapy of breast cancer.
    Zhang X; Li Y; Wei M; Liu C; Yu T; Yang J
    Drug Deliv; 2019 Dec; 26(1):129-136. PubMed ID: 30798640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin Loaded Silica Nanoparticles with Dual Modification as a Tumor-Targeted Drug Delivery System for Colon Cancer Therapy.
    Lin YQ; Zhang J; Liu SJ; Ye H
    J Nanosci Nanotechnol; 2018 Apr; 18(4):2330-2336. PubMed ID: 29442900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein-decorated and Adriamycin-loaded silica nanoparticles for tumor-targeted chemotherapy of colorectal cancer.
    Shi G; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Zhang R
    Adv Clin Exp Med; 2019 Apr; 28(4):479-487. PubMed ID: 30070081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cetuximab-Coated Thermo-Sensitive Liposomes Loaded with Magnetic Nanoparticles and Doxorubicin for Targeted EGFR-Expressing Breast Cancer Combined Therapy.
    Dorjsuren B; Chaurasiya B; Ye Z; Liu Y; Li W; Wang C; Shi D; Evans CE; Webster TJ; Shen Y
    Int J Nanomedicine; 2020; 15():8201-8215. PubMed ID: 33122906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trastuzumab modified silica nanoparticles loaded with doxorubicin for targeted and synergic therapy of breast cancer.
    Meng LX; Ren Q; Meng Q; Zheng YX; He ML; Sun SY; Ding ZJ; Li BC; Wang HY
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S556-S563. PubMed ID: 30146920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy.
    Ye Z; Zhang Y; Liu Y; Liu Y; Tu J; Shen Y
    Int J Nanomedicine; 2021; 16():2443-2459. PubMed ID: 33814909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-pot green synthesis of doxorubicin loaded-silica nanoparticles for in vivo cancer therapy.
    Jiang S; Hua L; Guo Z; Sun L
    Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():257-263. PubMed ID: 29853089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.
    Li Z; Zhang L; Tang C; Yin C
    Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein decorated silica nanoparticles co-delivering sorafenib and doxorubicin for effective treatment of hepatocellular carcinoma.
    Ye J; Zhang R; Chai W; Du X
    Drug Deliv; 2018 Nov; 25(1):2007-2014. PubMed ID: 30799656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic Graphene Oxide for Dual Targeted Delivery of Doxorubicin and Photothermal Therapy.
    Lu YJ; Lin PY; Huang PH; Kuo CY; Shalumon KT; Chen MY; Chen JP
    Nanomaterials (Basel); 2018 Mar; 8(4):. PubMed ID: 29584656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
    Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
    J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low density lipoprotein modified silica nanoparticles loaded with docetaxel and thalidomide for effective chemotherapy of liver cancer.
    Ao M; Xiao X; Ao Y
    Braz J Med Biol Res; 2018 Jan; 51(3):1-10. PubMed ID: 29513882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin-tethered fluorescent silica nanoparticles for pH-responsive anticancer drug delivery.
    Zhang P; Kong J
    Talanta; 2015 Mar; 134():501-507. PubMed ID: 25618700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
    Kumar P; Tambe P; Paknikar KM; Gajbhiye V
    Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellulose conjugated FITC-labelled mesoporous silica nanoparticles: intracellular accumulation and stimuli responsive doxorubicin release.
    Hakeem A; Zahid F; Duan R; Asif M; Zhang T; Zhang Z; Cheng Y; Lou X; Xia F
    Nanoscale; 2016 Mar; 8(9):5089-97. PubMed ID: 26868866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.